Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|August 4, 2024
Longitudinal epidemiology of multiple sclerosis over 60 years in Newcastle, Australia: 1961 to 2021Steve Simpson-Yap, Vicki E Maltby, Stacey Hall, et al.
BMJ Neurology Open|July 22, 2022
Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational dataTodd A Hardy, John Parratt, Heidi Beadnall, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2020
Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudyNathaniel Lizak, Suzanne Hodgkinson, Ernest Butler, et al.
Neurology|March 11, 2014
Fingolimod after natalizumab and the risk of short-term relapseVilija G Jokubaitis, Vivien Li, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2017
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosisTomas Kalincik, Vilija Jokubaitis, Tim Spelman, et al.
Annals of Clinical and Translational Neurology|May 23, 2015
Predictors of disability worsening in clinically isolated syndromeVilija G Jokubaitis, Tim Spelman, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2015
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosisMatthew Warrender-Sparkes, Tim Spelman, Guillermo Izquierdo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 1, 2019
Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotypeYuan Zhou, Suzi B Claflin, Jim Stankovich, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2013
Predictors and dynamics of postpartum relapses in women with multiple sclerosisStella E Hughes, Tim Spelman, Orla M Gray, et al.
Multiple Sclerosis and Related Disorders|January 10, 2019
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort studyAi-Lan Nguyen, Eva Kubala Havrdova, Dana Horakova, et al.
Pageof 5